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Abstract. Currently, cell separation occurs almost exclusively by density gradient methods 
and by fluorescence- and magnetic-activated cell sorting (FACS/MACS). These variously 
suffer from lack of specificity, high cell loss, use of labels, and high capital/operating cost. 
We present a dielectrophoresis (DEP)-based cell separation method, using 3D electrodes on a 
low-cost disposable chip; one cell type is allowed to pass through the chip whilst the other is 
retained and subsequently recovered.  The method advances usability and throughput of DEP 
separation by orders of magnitude in throughput, efficiency, purity, recovery (cells arriving in 
the correct output fraction), cell losses (those which are unaccounted for at the end of the 
separation) and cost.   The system was evaluated using three example separations; live and 
dead yeast; human cancer cells/red blood cells; and rodent fibroblasts/red blood cells. A 
single-pass protocol can enrich cells with cell recovery of up to 91.3% at over 300,000 
cells/second with >3% cell loss.  A two-pass protocol can process 300,000,000 cells in under 
30 minutes, with cell recovery of up to 96.4% and cell losses below 5%, an effective 
processing rate >160,000 cells/second. A three-step protocol is shown to be effective for 
removal of 99.1% of RBCs spiked with 1% cancer cells, whilst maintaining a processing rate 
of ~170,000 cells/second.   Furthermore, the self-contained and low-cost nature of the 
separator device means that it has potential application in low-contamination applications 
such as cell therapies, where GMP compatibility is of paramount importance. 
Significance statement.   Cell separation is a fundamental process in biomedicine, but is 
presently complicated, cumbersome and expensive.  We present a technique that can sort 
cells at a rate equivalent to or faster than gold-standard techniques such as FACS and MACs, 
but can do label-free and with very low cell loss.  The system uses dielectrophoresis (DEP) to 
sort cells electrostatically, using a novel electrode chip that eschews microfabrication in 
favour of a laminate drilled with 397 electrode-bearing wells.  This high level of 
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parallelisation makes the system immune to the bubbles that limit labs-on-chip, whilst also 
increasing capacity and throughput to unprecedented levels, whilst the chip is cheap enough 






Since the separation of red and white blood cells was first reported in 1974 (1), the 
technology has become fundamental in the biomedical sciences. From isolation of diseased 
tissue to the identification of cells for therapeutic uses and the potential for regenerative cell 
based therapies, cell separation techniques are increasingly integrated into other fields such as 
biochemistry, electrical engineering, physics and materials science (2).  Three methods 
dominate cell separation.  Density gradient methods exploits differences in density between 
populations such as red/white blood cells.  Fluorescently-activated cell sorting (FACS) uses 
fluorophore-conjugated antibodies as a discriminator; cells are launched in droplets, each 
containing one cell, through a fluorescence detection system to determine the cell type and 
are then electrostatically diverted into different output receptacles (3).  FACS can sort up to 
50,000 cells per second, with higher rates achievable at the cost of purity. Finally, 
magnetically-activated cell sorting (MACS) uses magnetic microbeads conjugated with 
antibodies. These bind to targets on cell surfaces, which then can be extracted by applying a 
magnetic field (4).  
However, the three methods have drawbacks.  Only density gradient does not require the use 
of chemical labels; the others use fluorescent chemicals or antibodies to indicate the target 
population.  These are expensive and may have limited specificity; in the case of MACS, the 
target protein must be present on the surface of the cells. Following separation, the labels may 
also persist in the cells, limiting their usefulness.  Cell losses in FACS and MACS can exceed 
half the population, particularly at high sorting rates (5,6).  FACS machines (particularly 
high-throughput devices) are very expensive and are not easily cleaned, rendering cell 
populations separated by this method non-compliant with good manufacturing practice 
(GMP). Finally, as the cell preparation includes a period during which labels are added and 
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then given sufficient time to conjugate, the total time to perform the sort can extend over 
several hours. 
There have been many attempts to develop cell separation techniques that are affordable to 
buy and use, do not require labels, and are able to retain significant numbers of cells.  An 
alternative separation technique is dielectrophoresis (DEP). A polarisable particle suspended 
in a non-uniform electric field (7) interacts with the field gradient, inducing a dipole. The 
interaction of dipole and field gradient produces different Coulomb force on either pole, 
inducing motion up or down the high field gradient according to the polarity of the dipole.  
The magnitude and polarity of the dipole itself is governed by the electrical properties of the 
cell (resistance and capacitance of membrane and cytoplasm) and medium, and the frequency 
of the electric field.  DEP can be used both to characterize and separate cells according to the 
passive electrical properties; where two cell types experience a field gradient at a frequency 
such that one cell type is attracted to the electrodes, one repelled. The repelled cells pass 
through the device unaffected, but the others are attracted to, and retained by, the electrodes 
acting as an “electrostatic filter”.  When the field is removed, these cells are released and can 
be collected separately. For example, Figure 1 shows spectra of two identical cell types, save 
that one has double the membrane capacitance of the other.  The highlighted frequency range 
indicates where one cell types experiences positive DEP, the other negative.  DEP spectra can 
be determined by commercial devices such as the DEPtech 3DEP, and exploitable differences 
can be readily identified by visual inspection.   
DEP separation of live and dead yeast cells was first demonstrated in 1966 (8).  Subsequent 
research demonstrated separation of cancerous and healthy cells, gram-negative and gram-
positive bacteria, stem cell subpopulations, different types of viruses, of for sample 
preparation whilst differences between cells indicated the potential for DEP to fraction 
leukocyte subpopulations (9-20). However, few approaches to DEP have been able to 
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compete with MACS or FACS; implementations often suffer from cells being trapped in 
interconnecting tubing, devices requiring small chamber heights to ensure cells pass close to 
the electrodes, restricting throughput and ultimately limiting total cell capacity; and the high 
cost of manufacturing, making it difficult to mass-produce the separator as a reliable, 
disposable component.  There are exceptions; the ApoStream method (21) can isolate 
significant numbers of circulating tumor cells (CTCs) from 12 million nucleated peripheral 
blood cells in 60 minutes (5,000 cells s-1). Hu et al. (22) reported separating 10,000 cells per 
second, but required the use of chemical labelling. Lee et al (23) reported a rate of 616 cells s-
1. Markx et al. (24) processed live and dead yeast cells at 107 cells ml-1 with purity in excess 
so 93%; however, the total capacity of the device was only 50µl, limiting overall throughput. 
An alternative approach to DEP separation used 3D chips constructed from interleaved 
conducting and insulating sheets with holes or “wells” drilled through (25). The first 
prototype sorted 50:50 live and dead yeast to 86:14 at 0.4 ml min-1.  A subsequent design (26) 
included remixing by passing a through multiple wells, producing high cell recovery (>90) 
but low throughput (25µl min-1).   
To be comparable to FACS or MACS requires cell sorting at rates in excess of 105 s-1 with 
minimal cell loss, high purity, low cost and highly robust.   Here we describe an 
electrophysiology-activated cell enrichment (EPACE) method employing a chip with 397 
holes of 400 µm diameter drilled through a laminate of 12 conducting layers separated by 
insulators, though which 397 wells with 400 µm diameter were drilled.  As shown in figure 2, 
this creates 397 parallel paths through the chip, each with 12 electrodes along the bore.  This 
high degree of parallelization, and the fact that all cells are no more than 200 µm from the 
electrodes, allows very high cell processing rates whilst minimising cell loss, and creates 
immunity from bubbles (which will, at worst, block only one channel).  Consequently, the 
system can separate cells at rates substantially in excess of 320,000 cells s-1 measured across 
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all cell types studied, separating populations in excess of 108 cells into output receptacles in 
under 30 minutes with cell losses as low as 0.3%, and separation efficiencies as high as 
96.4%, achieving more than 30 times higher throughput of previous DEP devices.   
2. Results  
2.1. Cell enrichment using a single-pass protocol. 
To assess separation efficacy, binary mixtures of cells were processed through the device in 
5-15ml units, processed at between 15,000 – 33,000 cells s-1, the results of which are 
summarised in Figure 3. Live and dead yeast showed mean recovery (the proportion of cells 
output in the correct outlet) of 81.3% and 89.5% respectively; vole blood and fibroblasts 
showed separation efficiencies of 87.3% and 73.9% respectively.  Purities (the proportion of 
required cells in the output population) at the output for the above populations were 91.3% 
and 78.2%, for live and dead yeast, and 75.6% and 86.4% for vole RBCs and fibroblasts. 
Whilst these values are low when considering the technique as a separation per se, they 
represent sufficiently high values to constitute effective cell enrichment.  It is also significant 
that for the above population sorts, the mean cell losses (cells which were input but are 
unaccounted for at the output, due to damage, adherence to the electrodes or device casing; or 
being left in residual liquid in the device at the end of the experiment) were 1.4%, 2.7%, 4%, 
and 0.3%, respectively.  These low cell losses are important for two reasons; firstly, multiple 
passes can be used to improve performance without significantly degrading cell numbers; 
secondly, unlike methods such as FACS where a significant number of cells being separated 
are destroyed by the separation process (6), this protocol does not reduce cell number – an 
important issue where initial cell numbers are low.   Experiments at 0.5 and 0.8 and 1.0 ml 
min-1 yielded similar results, suggesting these metrics represented a plateau of trapping 
efficiency, and that the device was working well within its performance limit.   
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To assess the viability of cells post-sort, collected fibroblasts were suspended in fibroblast 
growing medium, divided into two T75 flasks and placed in the incubator to assess growth 
potential. The cells were observed 1 and 3 days after incubation and were found to have 
adhered to the flask and reached confluency respectively. A DEP spectrum of the cells was 
obtained and a further passage performed to check for abnormalities and none were observed. 
In order to identify the upper throughput limit, live yeast cells were captured in the device in 
increasing concentrations, as it is the fraction of cells experiencing positive DEP that are 
limited by the capacity and efficacy of the DEP electrodes (the other, repelled, population 
simply passing through the device unaffected).  Retaining the 1ml min-1 flow rate, the 
concentration of cells per ml was increased from 106 ml-1 to ~2x106, 5x106, 107, 2x107 and 
108 cells ml-1. Chip saturation was monitored in two ways: firstly, we measured the total 
number of cells retained in the chip and subsequently recovered.  Secondly, cells were 
aliquoted in 1ml fractions and analysed to determine the cell ratio in order to observe trap 
saturation. Saturation can then be detected by the appearance of a higher proportion of live 
cells in the output stream. Any saturation effect would only affect cells collected by positive 
DEP on the electrodes; cells experiencing zero or negative DEP pass through the chip 
unimpeded and are collected in the receptacle below, and as a consequence there is no 
saturation limit on such cells.  
At concentrations up to 2.7x107 ml-1 the device worked as for 1x106 ml-1.  When 
concentrations of 2.7 x 107 ml-1 were used, the aliquots were normal and the mean cell 
recovery was 279±12.2 million cells.  When the input concentration was 5.9 x 107 ml-1, the 
number of cells increased dramatically (by over 300%) at the 6th aliquot, and the mean total 
of recovered cells was 321±9.0 million cells; when 1.07 x 108 ml-1 were used, the device 
became saturated after the 3rd aliquot (rising by 38% in aliquot 4, rising to >100% in aliquot 7 
and later), and recovery indicated that the trap contained 359±13.3 x 106 cells.  After the 
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separation run was completed, the cells collected in the chip were flushed and counted. In the 
three instances where the chip was saturated, the number of cells retained before the chip was 
saturated, with upper limits of approximately 350 x 106 cells representing the capacity of the 
chip.  
The difference in capacity between 59 million and 109 million cells/ml is interesting, as it 
suggests the trap capacity may be increased at high concentrations due to cell-cell 
interactions; however, it appears clear that a 300 x 106 cell sort (20 million cells/ml, 15 ml 
total volume) represents the maximum effective cell separation where the cell content is 
entirely unknown, though this represents the limit only on the positive DEP fraction; a sort of 
300 million cells experiencing positive DEP from a further 300 x 106 (or more) experiencing 
negative DEP would in principle be entirely workable, raising the throughput past 0.6 x 109 
cells/ml. 
 2.2. High-volume separation performance using multi-pass protocols 
Whilst enrichment on this scale is of interest, a second or third pass through the device 
enables the user to collect cells that were not retained in previous passes, significantly 
improving performance in a very short time.  There are two strategies for multiple sorting 
passes; re-sorting the effluxed and retained cells, respectively. Here we examine these two 
protocols separately; a two-pass strategy re-processing the effluxed cells to minimise cell loss 
whilst maximising enrichment in the shortest possible time, and a three-pass strategy where 
the collected cells are re-processed. 
Enhancing the negative DEP population.  We sorted mixtures of 9.6 - 14 x 106 cells 
(similar to the cell number in a confluent T175 flask) at concentrations of 1-2 x 106 cells ml-1 
and passed through the EPACE twice.  After each run, the chip was flushed with fresh 
medium to recover cells retained by positive DEP before the output was reprocessed. 
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Negative DEP was used to select the dead cells from mixtures of live and dead yeast cells, or 
RBCs from mixtures of RBCs and fibroblasts, the results of which can be seen in Figure 4.  
After the second pass the purity of dead yeast was increased to 93.4%; whilst the RBC 
fraction increased to 93.8%.  However, recovery was reduced, falling to 81% and 73.7% 
respectively, though these are still substantially above recovery rates for FACS and MACS.  
Overall cell losses (cells not appearing in either outlet) were 2.7% and 4%, with the 
remaining cells appearing in the other (waste) output.  We postulated that the values of 
separation efficiency for the populations experiencing negative DEP were adversely affected 
by cells being trapped in the dead volume between the chip and outlet, which were then 
recovered with the retained cells rather than passing to the effluxed portion.  In order to 
verify this we performed a separation of 20ml of RBC/fibroblast cells at the same 
concentration.  After the second pass, the recovery of RBCs was broadly similar at 87.8%, 
but the purity raised to 96.6%.   
Enhancing the positive DEP population.  An important application of cell separation is the 
enrichment of relatively rare subpopulations.  In order to use the EPACE platform to enrich 
highly asymmetrical cell concentrations a 3-pass strategy was used, with the cell fraction 
retained in the electrodes being retrieved and then subject to two further iterations (total time 
taken ca. 30 minutes). The cells collected were counted after each pass, and the ratio of cell 
types was determined. These results are summarised in Figure 5.   Human red blood cells 
were spiked with MDA-MB-231 breast cancer cells, to a final concentration of 1.1% cancer 
to 98.9% RBCs, at a total cell concentration of ca. 2 x 107 ml-1, to a total sample volume of 
4ml.  Cells were passed through the device at 0.5 ml min-1. After the cells mixture had 
completed its first pass through the device, the fraction retained in the device was released in 
1ml of fresh medium which was topped up to 3 ml with fresh medium after cell counting.  
Sampling indicated that the concentration of RBCs had dropped to 95.5% of the output.  The 
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3 ml of solution was then subject to a second pass and resuspension, at which point RBCs had 
dropped to 75.6%; and after the third pass, RBCs made up 59.5% of the cell sample, with 
cancer cells forming the remaining 40.5% of the cells, an effective removal rate of the RBCs 
of 99.1%.  At the end of the process, on average 47.7% of the initial population of cancer 
cells were recovered. However, those that had not been collected in the initial sort would be 
available for re-sorting in the waste from the previous passes, which could be used to 
significantly increase cell recovery if required, by adding an additional pass on the eluted 
cells.  
3. Discussion 
3.1 Analysis of performance.  
Whilst purity of sample at output is the final arbiter of the quality of a separation/enrichment 
method, it is difficult to use as a guide as it depends on the concentration of the two cell types 
at the input.  Instead, we can look at the concentration of both the desired and undesired cells.  
Analysing the 2-pass protocol to enrich live dead yeast and RBC/fibroblast cells by negative 
dielectrophoresis, the population experiencing negative DEP has recovery of approximately 
90% for the desired cells and 20% for the undesired fraction for each round of enrichment. 
After two passes, these are approximately squared, such that approximately 0.81x the desired 
and 0.04 undesired cells are present at the output, leading to a purity of 0.81/(0.81+0.04) = 
95.3%, in line with experimental results.  Similarly, for enrichment of cells experiencing 
positive dielectrophoresis, across the three rounds of separation the same process was 
observed, with an average of approximately 80% of MDA cells and 20% of RBCs appearing 
at the output for each round of enrichment.  Over successive passes, this predicts RBC 
proportions of 96%, 86% and 60% in line with observations. The cell losses are sufficiently 
low for them to be disregarded in the calculation.  
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3.2 Effect of Design on Optimum Performance 
From our results, it is possible to identify ways to optimise the cartridge design and increase 
separator performance by improving the values of cell recovery for the wanted and unwanted 
cells.  Notably, whilst the peak values of recovery and purity are high, it is the passed cells 
that have the highest purity, whilst retained cells always have the highest recovery. As 
configured, the device contains two “dead volumes” of sample that cannot be recovered at the 
end of the experiment.  One occurs due to the use of a conical syringe plunger; at maximum 
insertion the tip of the cone touches the chip, 0.56 ml of unseparated cells remain surrounding 
the plunger tip.  Similarly, approximately 0.54 ml of post-separation cells remain in the space 
between the chip and outlet. Consider a mixture of two populations A and B, where 
population A experiences negative DEP and passes through the chip whilst population B is 
retained by positive DEP; the mixture is contained in a 10ml sample. After the solution is 
passed through, 1.1ml (11%) of cells remain in the dead volume, limiting maximum recovery 
of A to 89%.  However, purity is unaffected because only the cells which have been passed 
through by the chip are collected. When the solution has been processed, we then draw 1ml 
into the device and release population B.  However, the device also contains 1.2ml of the 
original cell mixture, containing cells from population A.  This means that the recovery rate 
for mixture B is as high as can be obtained (since all of the cells are in the extracted volume), 
but the purity is downgraded by the presence of population A cells in the dead volumes.  In 
effect, the dead volumes act to take cell mixtures intended for the output for population A, 
and deposit them in the output to population B.  Whilst a future embodiment of the device 
could reduce the dead volumes by redesigning the plunger and outlet path, we can calculate 
the effective peak separation by mathematically removing the cells in the dead volumes.  We 
estimate that using this approach, the recovery of RBCs and purity of fibroblasts in the 
separation described above would equal or exceed the same parameters for the two 
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parameters unaffected by the dead volumes, which is to say that all purities and recoveries 
would exceed 95% for a two-pass strategy.  
The design outlined in this paper is a proof of concept, but a number of design modifications 
suggest themselves to improve simplicity, throughput, and capacity.  For example, the device 
presented here is loaded manually by drawing the syringe plunger upwards.  This means there 
is little control of the flow rate during loading; hence, during this time, the chip is not 
energised. However with the application of a bidirectional syringe pump that can both push 
and pull, it would be possible to separate on both draw and expel cycles, making separation 
simpler and more efficient. The single inlet of the cartridge also lends itself to combining 
with simple liquid handing /fraction collection systems, allowing automation of complex 
multi-pass protocols without user intervention. It is also evident that the design presented 
here could be modified to increase throughput.  For example a second chip, independently 
energised, could be mounted below the first to permit a second stage of separation; this could 
either be at the same frequency as the first, doubling the separation rate by removing the 
necessity for two separation passes, or at a different frequency to allow two-parameter 
sorting, whilst requiring no further antibodies (as would be required for FACS and MACS), 
making for a negligible cost increase over a single-chip version.  Similarly the throughput 
and total cell capacity could be increased by enlarging the chip and increasing the number of 
wells; this could be achieved by making a single electrode disk larger, or otherwise 
increasing the number of wells For example, a chip with a ca. 3500 wells could potentially 
separate up to 1010 cells in a similar 30 minute period, potentially allowing separation on 
industrial scales, or clinical applications such as sorting of stem cells from bone marrow. 
3.3. Comparison to other separation methods 
As described earlier, cell separation methods requiring more sensitivity than density gradients 
can be addressed by two methods; FACS and MACS.  A high throughput FACS system is 
14 
 
expensive; both FACS and MACS require expensive labels, and can only separate cells on 
the basis of this labelling.  The EPACE system presented here separates on the basis of 
physical parameters without the need for labels, and both the instrumentation (pump and 
generator) and consumables required (media, chips) are an order of magnitude less expensive 
than either method.  Furthermore, the system presented here could be manufactured as a fully 
assembled, sterile, integrated cartridge; with no crossover possible with other reparation runs, 
and no residual chemical labels to adversely affect cells, this allows the cells produced to be 
fully compliant with Good Manufacturing Practice (GMP).   
Cell throughput rates also compare well with other methods.  High throughput FACS cell 
sorters can process up to 100,000 events per second, though a relatively small proportion of 
these may actually contain cells.  MACS is a bulk method rather than processing cells 
serially, but the time taken to prepare and perform separation is comparable to the method 
presented in this paper.  Similarly, the number of cells to be separated by high volume MACS 
systems is 109 cells; whilst no upper limit for FACS has been identified, a wide review of the 
literature report few studies exceeding 2 x 107 cells; baseline EPACE performance is 
comparable to MACS, and better than FACS.  For example, the capacity of the device is 
approximately 4 x 108 yeast cells; balancing the relatively small size (and hence higher 
packing density) of such cells against the fact that DEP trapping force scales with cell 
volume, a capacity of >108 mammalian cells is certainly not unreasonable.  In terms of 
throughput, if we divide the number of cells processed by the time required for a two-pass 
sort, we have an effective sorting rate of 167,000 cells per second; adding in a third sort, as in 
the case of the rare cell study, still gives a nett throughput comparable to high-throughput 
FACS. Considering cell loss, EPACE is shown to be comparable to, or better than, either 
existing method.  In no case were more than 7% of cells lost, and in many cases fewer than 
3% of cells were lost.  By comparison, FACS typically loses >50% of cells through cell 
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damage during droplet formation or rejection due to incorrect scanning, particularly at higher 
flow rates (5).  When used in three-pass mode, cell recovery was lower, but the cells not 
initially captured by the device will be available for re-sorting in the outlet stream by using a 
more complex multiple-run separation strategy. 
Comparing our method to published DEP methods, the EPACE process is 30x faster than the 
Hu et al. (22) system, 6x faster than the Gupta et al. (21) system, and 600x faster than the 
system presented by Lee (23), with comparable or better cell recovery and cell losses.  The 
cell concentration and recovery were comparable to the Markx et al. system (24); without 
additional data we cannot compare throughput or cell loss. As these devices were 
microfluidic, we suggest that the system presented here should be significantly more robust; 
whereas the function of planar microfluidic devices can be compromised by the presence of a 
single bubble, the highly parallel design of our chip means that if a bubble appears it has no 
more effect potentially blocking just one of the 397 holes.   
Unlike FACS and MACS, which sort cells on the basis of specific recognition of membrane 
proteins, DEP separates on the basis of differences in the electrophysiology of the two cell 
types.  This offers advantages over these existing methods, as many differences in cell types 
(and changes in cells in response to external stimuli) exhibit corresponding differences in the 
cell’s electrophysiome.  Examples have included the differentiation of neural stem cells, 
where electrical changes in the membrane allow sorting of cells according to differentiation 
fate far in advance of conventional marker-based methods e.g. (27- 29); indeed, stem cell 
sorting may be an area where DEP-based separation may dominate over existing methods, 
whilst DEP separations in cancer cells have been reported for some decades (13), both for 
diagnosis and development of interventions.  Many other cases of differential DEP response 
have been identified in the past 50 years, and all past demonstrations can be performed using 
this platform (30). Once differential electrophysiology is established by DEP profiling, it can 
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be exploited through the use of ion channel blockers to emphasise difference and enhance 
DEP separation (31). 
In conclusion, we have presented a DEP-based cell separation technique that has a capacity 
and throughput comparable to the fastest MACS and FACS machines, requires no chemical 
labels, offers GMP compatibility, significantly lower cell loss, and significantly lower capital 
and running costs. Given the opportunity to exploit differences in cell electrophysiology in 
fields such as stem cell therapy and cancer, we believe this offers significant promise as a 
new standard benchtop laboratory technique. 
Materials and Methods 
Experiments followed the steps outlined in figure 6. The cartridge and chip were cleaned with 
ethanol before assembly. The chip manufacture and cell mixtures are described in the 
Supplementary Material.  A sample containing a mixture of the two cell types A and B was 
loaded into the fluidic cartridge by inserting the tube into the solution, then manually 
withdrawing the plunger to load the reservoir.  This was then placed in a vertically-mounted 
syringe pump (Razel, Stamford, USA; maximum output of 1 ml/min), and the solution was 
pumped through the chip whilst voltage was applied to the electrodes using signal generator 
(Jupiter 2000, Blackstar, St Ives, UK), connected to the chip via a custom-made amplifier 
board to supply up to 18Vpp at frequencies up to 1MHz. The output (enriched for population 
A) was collected in a second receptacle. Then fresh solution was loaded into the cartridge, the 
field was deactivated, and the chip was flushed manually with fresh medium to dislodge and 
recover the cells from population B that had been collected by positive DEP. When using a 
second pass or third pass, it was possible to enrich either cell-A or cell-B samples by 
repeating the procedure with the enriched samples.  The total time for the two-pass procedure 
was under 30 minutes for yeast, and under 15 minutes for RBC/fibroblasts. Cells were 
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exposed to the electric field for an average of approximately 5 minutes for the positive DEP 
fraction, or under 10 seconds for the negative DEP fraction. All experiments were repeated 
three times. For the three-pass experiments to enrich rare cells, at the end of the second and 
third pass the cells were recovered by switching the field off, manually pulling the plunger up 
slightly aspirating air into the fluidic cartridge and expelling the retained cells in the small 
sample volume that is still within the chip.  Separations were evaluated for cell recovery (the 
proportion of desired cells which arrive at the correct outlet), purity (the proportion of desired 
cells in a given outlet) and cell loss (the number of cells which are unaccounted for at the end 
of the separation). The number of missing cells was obtained by subtracting the ‘passed’ and 
‘recovered’ populations from the initial number of cells.   
DEP spectra of individual cell types were measured using a DEPtech 3DEP (Uckfield, UK) 
and a separation frequency midway between the crossover frequencies (the frequency on the 
DEP spectrum where the response crosses zero) for the two cell types to be separated; for the 
live/dead yeast mixture, 1 MHz was selected; for the fibroblast/RBC mixture, 22 kHz was 
selected; and for the MDA/RBC mixture, 76 kHz was used.  Cells in output mixtures were 
either identified by the use of Trypan blue (live and dead yeast) or by visual inspection of the 
morphologically quite different RBCs and fibroblasts/MDAs.   
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Figure Legends 
Figure 1.  DEP spectra of two arbitrary cell types, whose properties are identical save for one 
(blue line) having a membrane capacitance twice that of the other (red line).  In the frequency 
band (highlighted), the polarisabilities (and hence direction of force) of the two cells is 
different, enabling the cells to be separated.   
Figure 2 (a). A photograph of the DEP separation chip.  The chip is 30mm x 20mm in size. 
The inset section (red) shows a close-up of the chip, showing the electrodes along the inside 
of the wells.  The section of the chip in the image is approximately 5mm square.  (b) A 
schematic of chip, showing the three modes of DEP behaviour.  Cells flow from top to 
bottom through the wells; in the left well cells can be seen experiencing positive DEP, are 
attracted to the electrodes and held; in the center well cells experience negative DEP, and are 
repelled into the centre of the well and pass through. In the third well, cells experience no 
DEP force. In reality, cells of the same type will experience the same mode of behaviour in 
all wells on the chip, but two different cell populations can exhibit different behaviors to each 
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other. If one subpopulation experiences positive DEP and the others exhibit negative or 
neutral behaviour, they can be separated. (c) The chip is loaded into a fluidic cartridge 
comprising two parts; an upper part B contains both housing and plunger, whilst a lower part 
A collects the cell solution.  The chip fits between the two, sealed on both sides by O-rings, 
and is clamped together by three Allen bolts. 
Figure 3.  The average (n=3) results of the enrichment of mixtures of (a) live and dead yeast 
and (b) RBCs and fibroblasts, showing the total cell number in each case.  “Initial” refers to 
the numbers at the start of separation, “Passed” represents the cells collected during the 
separation, “Recovered” represents those cells collected by positive DEP and subsequently 
removed, and “Lost” is those unaccounted for.  Cells were processed through the device at 
approximately 1 million cells in 1 ml per minute. 
Figure 4. The average (n=3) results of a second stage of separation of mixtures of (a) live and 
dead yeast and (b) RBCs and fibroblasts, showing the total cell number in each case. For the 
second step, the cell population experiencing negative dielectrophoresis was reprocessed.  
“Initial” refers to the numbers at the start of separation, “Outlet” represents the cells collected 
during the separation, “Waste” represents those cells collected by positive DEP and 
subsequently removed, and “Lost” is those unaccounted for.  Cells were processed through 
the device at 1 ml per minute; with an initial cell concentration of approximately 1 million 
cells ml-1. 
Figure 5. Enrichment of MDA cancer cells cancer cells from RBCs, at an initial ratio of 1:99, 
average (n=3) results using a three-pass protocol. (a) The percentage of RBC cells in the 
sample, per run.  (b) The mean (n=3) overall recovery of the two cell types after each stage; 
the recovery of RBCs reaches a 99.1% suggesting that the cancer cells have been 
significantly enriched.  
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Figure 6. A schematic showing the separation procedure, which is divided into three steps.  In 
step 1, a mixture of cells in drawn into the syringe, through the chip. In step 2, the chip is 
activated and cells are expelled at typically 1 ml min-1. One cell type is retained in the 
electrodes whilst the other is eluted.  In step 3, after the solution is fully expelled, fresh 
medium is drawn into the device and expelled manually at a higher rate, whilst the retaining 




























Live and dead yeast. Yeast was grown using Tesco’s freeze dried baker’s yeast grown in a 
yeast extract peptone dextrose (YPD) medium (Sigma-Aldrich, U.K.) set overnight in an 
incubator at 37 °C. Yeast cells were killed by transferring live yeast in YPD medium to an 
incubator set to 70 °C for 3 hrs. Yeast was washed and suspended in DI water before use in 
experiments; conductivity was not fixed, but was at or below 1 mSm-1 (typically 0.2 - 0.5 
mSm-1).   
Rodent Fibroblasts and Red Blood Cells. 3T3 mouse fibroblasts, kindly donated by Dr 
Andrew Liu, University of Memphis, U.S.A., were cultured in an incubator set at 37 °C and 
5% CO2 in growth medium. Cells were cultured in DMEM (Sigma-Aldrich, U.K.) with the 
addition of 10% Fetal Bovine Serum (Fisher Scientific), 1mM sodium pyruvate (Sigma-
Aldrich, U.K.), 1% penicillin-streptomycin (Sigma-Aldrich, U.K.).   Adult common voles 
were sourced from the University of Surrey’s breeding colony in the UK, which was based on 
animals kindly donated by Professor Gerkema, University of Groningen, The Netherlands 
(S1-S3). Whole vole blood (1ml) was collected following published protocols (S4) using 
cardiac puncture, and collected in heparin coated tubes. Collection was followed by RBC 
isolation though three identical centrifugation steps (10 minutes, 1620g, 4C), each followed 
by resuspension of the RBC containing pellet in Phosphate Buffered Saline.  Finally, the two 
cell types were mixed and resuspended in DEP medium comprising de-ionised water 
supplemented with 8.5/0.3 % sucrose/dextrose (Sigma-Aldrich, U.K.), which were then 
washed and resuspended in DEP medium. The medium had a similar conductivity to the DI 
water sample described above. 
Human cancer and red blood cells. Human blood was collected from donors at the University 
of Surrey and RBCs were isolated following published protocols (S5). The RBCs which were 
then washed twice in DEP medium consisting of 8.5% (w/v) sucrose, 0.5% (w/v) dextrose, 
100µM CaCl2 and 250µM MgCl2.  MDA-MB-231 cells were culture in MEM medium 
(Sigma-Aldrich, UK) supplemented with 10% heat inactivated foetal bovine serum (FBS; 
Invitrogen, UK), 2mM L-Glutamine and 1% penicillin-streptomycin (Sigma-Aldrich, UK). 
The cells were grown in T75 flasks in a standard cell culture incubator at 5% CO2 95% 
humidified air at 37 °C and subcultured every 48 h when 80% confluent. To prepare for 
experiment, MDA-MB-231 cells were washed twice in a medium consisting of 8.5% (w/v) 
sucrose, 0.5% (w/v) dextrose, 100µM CaCl2 and 250µM MgCl2 and supplemented with 
NaOH to pH of 7.4. The medium conductivity was adjusted using PBS to 10 mS m-1.   
Preparation of Mixtures. Cell samples were prepared by counting using NanoEnTek C-chip 
disposable haemocytometer (Labtech, Uckfield UK), mixing to obtain an approximately 
50:50 ratio, then re-measured. The stock of live and dead yeast was found to contain 8.0 
million live cells and 6.0 million dead cells, which was processed as 15 ml samples (a 
concentration of 0.93 million cells ml-1).  Vole fibroblasts and RBCs were mixed, and the 
resultant mixture was measured to contain 5.1 million fibroblasts and 4.8 million RBCs in 
each of three 5 ml aliquots, a total concentration of 1.98 million cells ml-1. A 20ml sample of 
11.1million fibroblasts and 13.4 million RBCs was also prepared. Human red blood cells 
were spiked with MDA-MB-231 breast cancer cells, to a final concentration of 1.1% cancer 
to 98.9% RBCs, at a total cell concentration of ca. 2 x 107 ml-1, to a total sample volume of 
4ml.   
Device Fabrication  
The device comprised three principal parts; a fluidic chip, a casing, and the support 
instrument (including principally a signal generator, amplifier, and syringe driver).  The chip 
comprised ten layers of 70µm-thick copper separated by 150 µm-thick glass fibre reinforced 
epoxy (FR4) layers, with two further 35 µm-thick copper layers at the top and bottom. All 
copper layers were patterned in a circle slightly larger than the area through which the 
separation wells were drilled, to minimise overlap and associated capacitive losses.  397 
wells with a 400µm-diameter were drilled in a hexagonal pattern at the centre of the chip; 
larger holes for assembly and contacts were placed at the perimeter of the chip.  Exposed 
copper areas were gold-plated to maintain stability and biocompatibility. The chip was 
housed in a cartridge machined from PMMA, which comprised a reservoir containing a 
syringe plunger from a 20ml syringe, a chip holder, and an outlet.  The chip formed the base 
of the reservoir, such that when the plunger was pushed, cells were able to flow through all 
397 holes. Below the chip, a collection cone funnelled the suspension into a 1.46mm 
diameter outlet tube to a collection receptacle. The chip was mounted between top cylinder 
and bottom cone of the assembly and secured using Allen bolts, with a watertight seal 
provided by two 19.13mm-diameter O-rings.    
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